Human Milk Oligosaccharides Market

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan?s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

Human Milk Oligosaccharides Market contains market size and forecasts of Human Milk Oligosaccharides (HMO) in global, including the following market information:

Global Human Milk Oligosaccharides (HMO) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Human Milk Oligosaccharides (HMO) Market Sales, 2017-2022, 2023-2028, (Tons)

Global top five Human Milk Oligosaccharides (HMO) companies in 2021 (%)

The global Human Milk Oligosaccharides (HMO) market was valued at 357.8 million in 2021 and is projected to reach US$ 1015.9 million by 2028, at a CAGR of 16.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

2'-FL & 3-FL Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem and Dextra Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Human Milk Oligosaccharides (HMO) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Milk Oligosaccharides (HMO) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Human Milk Oligosaccharides (HMO) Market Segment Percentages, by Type, 2021 (%)

2'-FL & 3-FL

Sialyllactose

LNT & LNnT

Global Human Milk Oligosaccharides (HMO) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Human Milk Oligosaccharides (HMO) Market Segment Percentages, by Application, 2021 (%)

Infant Formula

Functional Food & Beverages

Food/Medical Supplements

Others

Global Human Milk Oligosaccharides (HMO) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Human Milk Oligosaccharides (HMO) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Milk Oligosaccharides (HMO) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Human Milk Oligosaccharides (HMO) revenues share in global market, 2021 (%)

Key companies Human Milk Oligosaccharides (HMO) sales in global market, 2017-2022 (Estimated), (Tons)

Key companies Human Milk Oligosaccharides (HMO) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott

Inbiose

Glycom

Chr. Hansen (Jennewein)

Elicityl SA

ZuChem

Dextra Laboratories